Xencor (XNCR) Reports Encouraging Preliminary Data from Ongoing Phase 1 Study of XmAb306; Reports Earnings

Go back to Xencor (XNCR) Reports Encouraging Preliminary Data from Ongoing Phase 1 Study of XmAb306; Reports Earnings
XENCOR (NASDAQ: XNCR) Delayed: 14.08 +0.07 (0.50%)
Previous Close $14.01    52 Week High $26.50 
Open $13.90    52 Week Low $9.89 
Day High $14.50    P/E N/A 
Day Low $13.90    EPS $-0.51 
Volume 1,142,490